Abstract
Who is Who in Clinical Diagnostics in China, produced jointly with the firm
McEvoy & Farmer, is the product of on-the-ground primary research on Chinese
labs conducted in fall and winter 2008.
Included in this report:
- Market Size Estimate by Major Category (Chemistry, Critical Care
Chemistry, Urine Chemistry, Hematology, Flow Cytometry, Coagulation,
Immunochemistry, Molecular Testing, Other IVD)
- Country Industry Overview
- Chinese Hospital Statistics
- Profiles of 42 International Diagnostic Companies with operations
in China
- Profiles of 130 Domestic Diagnostic Companies
- Profiles of 24 Local Distributors, indicating the companies they
distribute for
The Chinese market represents a significant opportunity for IVD diagnostic
companies. But actionable information about this emerging market is often
difficult to get. Only with an exhaustive, on-the-ground research team can a
company truly understand the chinese market. Now, a resource is available that
can make on-the-ground research available to all companies at a fraction of
the cost.
Published jointly with trusted Asian IVD market experts, this Kalorama report
is a complete survey of the IVD market in China today. Market size for major
categories of the IVD market, products on the market, important Chinese market
trends and intense company profiles are part of this exhaustive study.
This country of 1.3 billion people is now America' s sixth largest export
market, and China' s economy, while showing some effects of the world
recession, has been less impacted than other nations and is showing growth,
although not as rapid as in recent years. A number of recent events and trends
in the Chinese healthcare environment are making China an increasingly
attractive market opportunity for in vitro diagnostics companies. The
increasing numbers of private laboratories and expanded reference laboratories
are expanding the market for tests of all kinds.
Although there are a number of challenges for diagnostic manufacturers to
understand and overcome, the market for clinical diagnostics in China (both
reagents and instruments) remains one of the most promising emerging markets
in the world.
| 
View Cart
